GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fonar Corp (NAS:FONR) » Definitions » Price-to-Free-Cash-Flow

Fonar (FONR) Price-to-Free-Cash-Flow : 9.46 (As of Dec. 14, 2024)


View and export this data going back to 1981. Start your Free Trial

What is Fonar Price-to-Free-Cash-Flow?

As of today (2024-12-14), Fonar's share price is $15.53. Fonar's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $1.64. Hence, Fonar's Price-to-Free-Cash-Flow Ratio for today is 9.46.

The historical rank and industry rank for Fonar's Price-to-Free-Cash-Flow or its related term are showing as below:

FONR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.62   Med: 9.04   Max: 14.62
Current: 9.44

During the past 13 years, Fonar's highest Price-to-Free-Cash-Flow Ratio was 14.62. The lowest was 4.62. And the median was 9.04.

FONR's Price-to-Free-Cash-Flow is ranked better than
87.1% of 93 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.53 vs FONR: 9.44

Fonar's Free Cash Flow per Share for the three months ended in Sep. 2024 was $-0.03. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $1.64.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Fonar was 0.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -1.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -5.40% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -2.50% per year.

During the past 13 years, Fonar's highest 3-Year average Free Cash Flow per Share Growth Rate was 64.80% per year. The lowest was -28.20% per year. And the median was 0.40% per year.


Fonar Price-to-Free-Cash-Flow Historical Data

The historical data trend for Fonar's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fonar Price-to-Free-Cash-Flow Chart

Fonar Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.00 8.22 9.51 11.26 7.81

Fonar Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.40 10.67 11.11 7.81 9.86

Competitive Comparison of Fonar's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Fonar's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fonar's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fonar's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Fonar's Price-to-Free-Cash-Flow falls into.



Fonar Price-to-Free-Cash-Flow Calculation

Fonar's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=15.53/1.642
=9.46

Fonar's Share Price of today is $15.53.
Fonar's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.64.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Fonar  (NAS:FONR) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Fonar Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Fonar's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Fonar Business Description

Traded in Other Exchanges
Address
110 Marcus Drive, Melville, NY, USA, 11747
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
Executives
Timothy Raymond Damadian director, officer: CEO, President & Treasurer 110 MARCUS DR., MELVILLE NY 11747
Luciano B Bonanni officer: Exec VP, COO & PFO 110 MARCUS DR., MELVILLE NY 11747
Raymond V Damadian director, officer: president 31 FAIRBANKS BLVD, WOODBURY NY 11797
Robert J Janoff director 32 OSAGE DRIVE, HUNTINGTON STATION NY 11746
Data Charles O director 347 LINCOLN AVENUE, BEAVER PA 15009
Claudette Chan director 145 WEST 86TH STREET, APT. 15B, NEW YORK NY 10024
David B Terry officer: Secretary BOX 1439, EAST QUOGUE NY 11942
Robert Djerejian director 303 EAST 57TH STREET, APT 16LA, NEW YORK NY 10022